Identification of patients for clinical risk assessment by prediction of cardiovascular risk using default risk

Tom Marshall1

  • 1Department of Public Health & Epidemiology, University of Birmingham, Edgbaston, Birmingham, B15 2TT, UK. T.P.Marshall@bham.ac.uk

BMC Public Health
|January 25, 2008
PubMed

Insights

Primary care can identify high-risk cardiovascular disease patients using routine electronic health record data. This strategy is more effective than using age or treatment status alone for risk assessment.

Area of Science:

  • Cardiovascular disease risk assessment
  • Primary care informatics
  • Health services research

Background:

  • Identifying patients without cardiovascular disease (CVD) at high risk necessitates risk factor assessment.
  • Primary care providers need efficient methods to prioritize CVD risk assessment for at-risk individuals.
  • Utilizing routinely available electronic medical record (EMR) data with imputed values for missing blood pressure and cholesterol can estimate prior CVD risk.

Purpose of the Study:

  • To analyze the test characteristics of using routinely collected EMR data to identify patients at high risk of CVD.
  • To compare the effectiveness of a CVD risk estimation strategy using EMR data against strategies based on age or treatment status.

Main Methods:

  • Framingham cardiovascular risk estimates were calculated using data from the Health Survey for England 2003.
  • Receiver operating characteristic (ROC) curves were constructed to evaluate the ability of prior CVD risk estimates to identify patients with a >20% ten-year CVD risk.
  • Performance was compared against strategies using age, or diabetic and antihypertensive treatment status.

Main Results:

  • The area under the ROC curve (AUC) for prior CVD risk estimation using minimum EMR data was 0.933 (95% CI: 0.925–0.941).
  • This AUC was significantly higher than strategies based on age (AUC: 0.892, 95% CI: 0.882–0.902) or diabetic and hypertensive status (AUC: 0.608, 95% CI: 0.584–0.632).

Conclusions:

  • Routinely available primary care data can effectively identify populations at high risk for cardiovascular disease.
  • Leveraging information technology for patient prioritization in CVD prevention can enhance the efficiency of risk assessment in primary care settings.
Abstract

Related Concept Videos

Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT01:25

Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT

Calcium-Scoring CT ScanA calcium-scoring CT scan, also known as coronary artery calcium (CAC) scan, detects calcium deposits in the coronary arteries. This test assesses the risk of coronary artery disease (CAD), which can lead to cardiovascular events such as angina, heart failure, and sudden cardiac arrest.A calcium-scoring CT scan is generally recommended for individuals at intermediate risk of CAD without symptoms. It includes:Men aged 40-75 and women aged 50-75: Especially those with a...
Assessment of the Cardiovascular System I: Subjective Data01:23

Assessment of the Cardiovascular System I: Subjective Data

A thorough health history and physical assessment are essential for identifying cardiovascular disease (CVD) symptoms and distinguishing them from other health issues.
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Factors affecting Blood pressure01:28

Factors affecting Blood pressure

Several physiological and lifestyle factors influence blood pressure (BP). Understanding these factors is crucial as they are significant in patient education and blood pressure management.
Physiological Factors:
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...